Magnetic Resonance Imaging MRI and immunohistochemical investigations of CNS a...
Magnetic Resonance Imaging MRI and immunohistochemical investigations of CNS activity in a novel preclinical migraine model
This application is being submitted by Dr Milena De Felice of the University of Arizona (researcher), and Professor Fiona Boissonade of the University of Sheffield (scientist-in-charge and supervisor), who have complementary exper...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PROBING-PAIN
Multimodal functional neuroimaging techniques to probe the r...
1M€
Cerrado
SAF2010-19434
ESTUDIO DE LA CONECTIVIDAD FUNCIONAL CEREBRAL MEDIANTE LA RE...
97K€
Cerrado
PSI2013-48260-C3-2-R
MODULACION DE LA ACTIVIDAD CEREBRAL PARA ALIVIAR EL DOLOR: A...
85K€
Cerrado
PID2021-127703OB-I00
CARACTERIZACION DE LA CONECTIVIDAD NEURAL FOCAL, MEDIANTE RE...
93K€
Cerrado
EIN2019-103509
NUEVAS TECNICAS DE NEUROMODULACION NO INVASIVAS PARA COMPREN...
6K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
This application is being submitted by Dr Milena De Felice of the University of Arizona (researcher), and Professor Fiona Boissonade of the University of Sheffield (scientist-in-charge and supervisor), who have complementary expertise in different aspects of trigeminal pain. The project will be co-supervised by Dr Aneurin Kennerley, the lead physicist in the University of Sheffield's preclinical MRI facility. The proposed multi-disciplinary project will utilise magnetic resonance imaging (MRI) and immunohistochemical techniques to investigate altered activity in the central nervous system in a novel preclinical model of migraine. The over-arching aims of the project are to further understand the generation of migraine and its symptoms, and to identify the specific brain regions involved. The results of our studies will enable us to correlate MRI changes with the development of migraine-like symptoms and the expression of specific indicators of altered excitability. This will advance our understanding of the mechanisms underlying the development of migraine. We also aim to establish how anti-migraine drugs affect MRI and behavioural responses in our model. This project has the potential to establish a translational MRI model that could be utilised to identify and determine the efficacy of novel therapeutic strategies.